DAXOR CORP DXR Income Statement

Dec'11	Dec'10
Operating revenues - equipment sales and related services
1,125	1,242
Operating revenues - cryobanking and related services
321	336
Total Revenues
1,446	1,579
Costs of sales-equipment sales and related services
616	691
Costs of sales-cryobanking and related services
36	35
Total Costs of Sales
652	727
Gross Profit
793	851
Research and development-equipment sales and related services
2,508	2,826
Research and development-cryobanking and related services
197	215
Total Research and Development Expenses
2,705	3,041
Selling, general, and administrative- equipment sales and related services
3,219	2,750
Selling, general and administrative- cryobanking and related services
655	718
Total Selling, General and Administrative Expenses
3,874	3,469
Total Operating Expenses
6,580	6,510
Loss from Operations
-5,786	-5,659
Dividend income-investment portfolio
2,237	2,226
Realized gains on sale of securities, net
33	13,509
Mark to market of short positions
-8,501	-1,526
Other revenues
12	12
Interest expense, net of interest income of $6,425 and $1,944
-168	-61
Administrative expenses relating to portfolio investments
153	150
Total Other (expense) income, net
-6,541	14,009
(Loss) Income before income taxes
-12,327	8,350
(Benefit ) provision for income taxes
-5,142	3,381
Net (Loss) Income
-7,185	4,968
Weighted average number of shares outstanding basic and diluted
4,219	4,237
Net (loss) income per common equivalent share basic and diluted (in Dollars per share)
-1.70	1.17
Dividends paid per common share (in Dollars per share)
0.25	1.00